GLP-1 Drugs & Addiction

Ozempic, Wegovy & the Future of Addiction Treatment

GLP-1 receptor agonists are generating serious scientific interest as addiction treatments. Here's everything we know, the mechanism, the evidence, and what it means for recovery.

227K+
Patients in landmark study
4+
Substances showing reduced use
Phase 3
Trials underway for AUD
2028–32
Possible FDA approval window

Articles in This Series

Foundational

Does Ozempic Reduce Cravings?

The full picture, food, alcohol, nicotine, and beyond. How GLP-1 drugs quiet reward-seeking across the board.

Read the guide →
Mechanism & Science

GLP-1 Drugs for Addiction

Deep dive into the science, all four major GLP-1 drugs, the evidence base by substance, and what's coming.

Read the guide →
Alcohol

Ozempic and Alcohol

The 2024 Nature Communications study, the mechanism, safety interactions, and what it means for alcohol recovery.

Read the guide →
Clinical

Ozempic for Alcohol Use Disorder

Clinical evidence, Phase 2 trial data, comparison to naltrexone, and practical guidance for people in recovery.

Read the guide →

Behavioral support, today, not 2028

GLP-1 drugs may transform addiction treatment in the coming years. In the meantime, evidence-based behavioral tools work right now. Forge tracks your streak and helps you manage cravings day by day.

Download Forge Free
Track Your Quit, Free on iPhone